106 related articles for article (PubMed ID: 38751257)
21. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease.
Tian F; Zheng Z; Zhang D; He S; Shen J
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30473540
[TBL] [Abstract][Full Text] [Related]
23. Aspartate transaminase/alanine transaminase (De Ritis ratio) predicts survival in major burn patients.
Wang B; Hu L; Chen Y; Zhu B; Kong W; Zhu Z; Wang K; Yu Q; Zhang W; Wu G; Sun Y; Xia Z
Burns; 2022 Jun; 48(4):872-879. PubMed ID: 34456097
[TBL] [Abstract][Full Text] [Related]
24. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers.
Chan WK; Sthaneshwar P; Nik Mustapha NR; Mahadeva S
PLoS One; 2014; 9(9):e105903. PubMed ID: 25184298
[TBL] [Abstract][Full Text] [Related]
25. De Ritis ratio as diagnostic marker of alcoholic liver disease.
Majhi S; Baral N; Lamsal M; Mehta KD
Nepal Med Coll J; 2006 Mar; 8(1):40-2. PubMed ID: 16827089
[TBL] [Abstract][Full Text] [Related]
26. Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study.
Zou Y; Zhong L; Hu C; Sheng G
Lipids Health Dis; 2020 Nov; 19(1):245. PubMed ID: 33239040
[TBL] [Abstract][Full Text] [Related]
27. Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients.
Giandalia A; Romeo EL; Ruffo MC; Muscianisi M; Giorgianni L; Forte F; Cucinotta D; Russo GT
Prim Care Diabetes; 2017 Jun; 11(3):226-232. PubMed ID: 28017576
[TBL] [Abstract][Full Text] [Related]
28. Association between Serum Ferritin Level and Nonalcoholic Fatty Liver Disease in a Non-Obese Chinese Population: a Cross-Sectional Study.
Yao J; Dai Y; Zhang J; Zhang X; Zheng R
Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232044
[TBL] [Abstract][Full Text] [Related]
29. Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease.
Shin HK; Park JH; Yu JH; Jin YJ; Suh YJ; Lee JW; Kim W;
Sci Rep; 2021 Sep; 11(1):18004. PubMed ID: 34504179
[TBL] [Abstract][Full Text] [Related]
30. The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy.
Gorgel SN; Kose O; Koc EM; Ates E; Akin Y; Yilmaz Y
Int Urol Nephrol; 2017 Sep; 49(9):1577-1583. PubMed ID: 28669104
[TBL] [Abstract][Full Text] [Related]
31. Nonalcoholic fatty liver disease in morbidly obese subjects: correlation among histopathologic findings, biochemical features, and ultrasound evaluation.
Cazzo E; de Felice Gallo F; Pareja JC; Chaim EA
Obes Surg; 2014 Apr; 24(4):666-8. PubMed ID: 24415281
[TBL] [Abstract][Full Text] [Related]
32. The ZJU index is a powerful index for identifying NAFLD in the general Chinese population.
Li L; You W; Ren W
Acta Diabetol; 2017 Oct; 54(10):905-911. PubMed ID: 28698957
[TBL] [Abstract][Full Text] [Related]
33. The Symptoms of Gastroesophageal Reflux Disease Correlate with High Body Mass Index, the Aspartate Aminotransferase/Alanine Aminotransferase Ratio and Insulin Resistance in Japanese Patients with Non-alcoholic Fatty Liver Disease.
Fujiwara M; Eguchi Y; Fukumori N; Eguchi H; Tomonaga M; Yoshioka T; Hyakutake M; Sakanishi Y; Kyoraku I; Sugioka T; Fujimoto K; Kusano M; Yamashita S
Intern Med; 2015; 54(24):3099-104. PubMed ID: 26666594
[TBL] [Abstract][Full Text] [Related]
34. Sodium-Glucose Cotransporter-2 Inhibitors Ameliorate Liver Enzyme Abnormalities in Korean Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.
Euh W; Lim S; Kim JW
Front Endocrinol (Lausanne); 2021; 12():613389. PubMed ID: 34177796
[TBL] [Abstract][Full Text] [Related]
35. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
Kwo PY; Cohen SM; Lim JK
Am J Gastroenterol; 2017 Jan; 112(1):18-35. PubMed ID: 27995906
[TBL] [Abstract][Full Text] [Related]
36. Serum aminotransferase ratio is independently correlated with hepatosteatosis in patients with HCV: a cross-sectional observational study.
Lin MS; Lin HS; Chung CM; Lin YS; Chen MY; Chen PH; Hu JH; Chou WN; Huang JC; Huang TJ
BMJ Open; 2015 Sep; 5(9):e008797. PubMed ID: 26369802
[TBL] [Abstract][Full Text] [Related]
37. Lipoprotein A, combined with alanine aminotransferase and aspartate aminotransferase, contributes to predicting the occurrence of NASH: a cross-sectional study.
Zhang Y; He H; Zeng YP; Yang LD; Jia D; An ZM; Jia WG
Lipids Health Dis; 2020 Jun; 19(1):134. PubMed ID: 32527258
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
Panahi Y; Ghamarchehreh ME; Beiraghdar F; Zare R; Jalalian HR; Sahebkar A
Hepatogastroenterology; 2012 Oct; 59(119):2099-2103. PubMed ID: 23234816
[TBL] [Abstract][Full Text] [Related]
39. Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity.
Zhang J; Cao J; Xu H; Dong G; Huang K; Wu W; Ye J; Fu J
J Clin Lab Anal; 2021 Feb; 35(2):e23602. PubMed ID: 33249617
[TBL] [Abstract][Full Text] [Related]
40. Association of hepatic insulin resistance indexes to nonalcoholic fatty liver disease and related biomarkers.
Sesti G; Fiorentino TV; Hribal ML; Sciacqua A; Perticone F
Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1182-7. PubMed ID: 23419734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
